Endocrinology
Mitochondrial insults harm metabolic function in HIV/HCV co-infected patients
Published in AIDS Weekly, January 10th, 2005
"The 'metabolic syndrome' or 'syndrome X' affects approximately a quarter of the general population of the United States. A significant number of patients, therefore, may have predisposing risk factors for developing 'syndrome X' and/or diabetes mellitus (DM) prior to human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and/or institution of highly active antiretroviral therapy (HAART)," researchers in the United States report.
"Metabolic perturbations identical to 'syndrome X' develop in many HIV-infected patients who are undergoing highly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-01-10)
More Articles from AIDS Weekly
- HIV/AIDS Drug Screening
Novel method screens HIV-1 RT inhibitors based on based on dock-MM-PB/GS - HIV/AIDS Research
Cross-species transmission of SIV realized - HIV/AIDS Vertical Transmission
HIV-1-infected breast milk cells associated with risk of vertical transmission - HIV/AIDS-Associated Dementia
Brain dopaminergic transporters decreased in HIV-associated dementia - Breast Cancer
Benefits of bisphosphonate clodronate for breast cancer presented at symposium - Business Update
Biotech company to expand manufacturing capacity with California facility - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
